Tuesday, October 13, 2026||
MultiKhabarMultiKhabar
Home/finance/AbbVie reports positive Crohn’s disease trial results for Skyrizi

AbbVie reports positive Crohn’s disease trial results for Skyrizi

In
Investing.com
By Investing.com
10/13/2026, 7:20:41 PM
Share:WhatsAppFacebookX (Twitter)Telegram
AbbVie reports positive Crohn’s disease trial results for Skyrizi
EXECUTIVE SUMMARY

AbbVie reports positive Crohn’s disease trial results for Skyrizi....

Key Takeaways

  • AbbVie reports positive Crohn’s disease trial results for Skyrizi.

Share:WhatsAppFacebookX (Twitter)Telegram

Read Complete Original Article

Published originally on Investing.com

Visit Publisher Site →

Related News

How you can prepare for 6% bond yields
finance27 minutes ago

How you can prepare for 6% bond yields

Savers and investors at current yields stand to benefit, but fears are growing about the rest of the economy outside of the AI boom

MarketWatch Top Stories
Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!

Get it on Google Play